Sanofi opened at ₹2,932.80, in line with its previous close of ₹2,932.80. During today's session, the stock has traded between ₹2,907.40 and ₹2,969.80, with an average traded price of ₹2,942.26. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Sanofi is now worth
₹ 3,670.00
resulting in a loss of
₹ 6,330.00 (63.30%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+23.40 (+0.80%)
Day High
₹2,969.80
Day Low
₹2,907.40
Day Open
₹2,932.80
Prev Close
₹2,932.80
Volume
8,231
Value Traded
₹2.42 Cr
1W Return
-2.25%
1M Return
-3.99%
3M Return
-13.10%
6M Return
-15.34%
1Y Return
-37.09%
Market Cap (₹ Cr.)
6,808
PE Ratio
20.90
PB Ratio
8.18
Dividend Yield
2.56%
ROE
36.45%
ROCE
48.50%
Book Value (₹)
358.68
Face Value (₹)
10.00
EPS (TTM)
51.89
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-2.25%
6 Week
-
1 Month
-3.99%
3 Month
-13.10%
9 Month
-27.77%
Sanofi Q3FY26 Results: Aide-mémoire released for financial modelling
Sanofi released the aide-mémoire for Q3FY26 results on its investor portal. Document covers non-comparable items, FX impact, and share count for modelling. Q3FY26 earnings are scheduled for publication on October 30, 2026.
7 days agoDupixent MDL hearing opens as Sanofi faces CTCL warning allegations
First hearing held in Dupixent MDL alleging drug causes cutaneous T-cell lymphoma. FDA flagged CTCL as potential serious risk signal in March 2025. 2024 study found higher odds of CTCL in Dupixent-treated eczema patients. Plaintiffs argue Sanofi's internal materials acknowledged risk but label lacks warning.
7 days agoSanofi expands Regeneron pact, pledges up to $8 billion
Sanofi pays $1 billion upfront to expand partnership with Regeneron. Potential milestone payments for Regeneron reach up to $7 billion. New agreement covers four novel long-acting antibodies targeting interleukins. Dupixent sales rose 37.6% to €5.154 billion in Q2.
12 days agoSanofi India receives ₹16.40 Cr GST notice from Gujarat for FY23
Sanofi India received a ₹16.40 crore GST show cause notice from Gujarat authorities for FY23. This adds to an earlier ₹23.74 crore notice from Karnataka GST authorities for the same period. Total combined GST demand for FY23 stands at approximately ₹40.14 crore. Gujarat notice alleges E-Way Bill discrepancies, turnover reconciliation issues, and ineligible ITC claims. Company states no adverse impact on financials is envisaged while examining the notices.
14 days agoSanofi India promoter group shifts 15.20% stake via block deal
Hoechst GmbH transferred 3.5 million shares to Sanofi Healthcare India Pvt Ltd. Stake shift represents 15.20% of total equity capital via block deal. Total promoter group holding remains unchanged at 60.40%. Acquisition price set at ₹3,052 per share, below VWAP benchmark cap.
15 days agoSanofi India large-trade signal: ₹1,068.2 crore at ₹3,052 in pre-open
A large-trade signal flagged approximately 35,00,000 Sanofi India shares on NSE during the pre-open session. The indicated combined value of the flagged activity stands at ₹1,068.2 crore at a price of ₹3,052 per share. This is a real-time trade-scanning signal and is not a confirmed exchange-reported event. Official large-trade disclosures by NSE/BSE are published only after market close, typically after 3:30pm.
19 days ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Sanofi is now worth
₹ 3,670.00
resulting in a loss of
₹ 6,330.00 (63.30%)
Note: Past profits do not guarantee future returns.